PIB News
Trade Margin Cuts Announced for 137 Anti-Cancer Drugs
The Ministry of Chemicals and Fertilizers has announced a Trade Margin Rationalisation (TMR) for 137 anti-cancer drugs, effective November 9, 2026. This initiative, led by the National Pharmaceutical Pricing Authority, aims to reduce excessive trade margins and make cancer treatments more affordable. The revised pricing could lower the maximum retail price of these drugs by up to 70%, benefiting patients who rely on medications like Pembrolizumab and Bevacizumab. This move follows a successful 2019 pilot program that capped trade margins for 42 anti-cancer drugs, resulting in significant price reductions for various medicines.
The Radius summarizes this story. Read the original report from PIB News.
Read Full